Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS) / Feliciani, Claudio. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - 103:(2011), pp. 113-120. [10.1016/j.ymgme.2011.02.018]

Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS).

FELICIANI, Claudio
2011-01-01

2011
Incidence and timing of infusion-related reactions in patients with mucopolysaccharidosis type II (Hunter syndrome) on idursulfase therapy in the real-world setting: a perspective from the Hunter Outcome Survey (HOS) / Feliciani, Claudio. - In: MOLECULAR GENETICS AND METABOLISM. - ISSN 1096-7192. - 103:(2011), pp. 113-120. [10.1016/j.ymgme.2011.02.018]
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1096719211000618-mainHOS.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 470.04 kB
Formato Adobe PDF
470.04 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2765954
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 48
social impact